Navigation Links
Massachusetts General Hospital's Warren Triennial Prize to honor pioneers of cellular reprogramming
Date:12/16/2010

The 2011 Warren Triennial Prize of Massachusetts General Hospital (MGH) will be awarded to Shinya Yamanaka, MD, PhD, who discovered a method to convert adult cells into cells with characteristics of embryonic stem cells, and Rudolf Jaenisch, MD, whose extension of Yamanaka's work includes using those cells to generate animal models of important human diseases. The award will be presented at a daylong symposium in October 2011, part of the celebration of the 200th anniversary of the founding of the MGH. Yamanaka is director of the Center for iPS Cell Research and Application at Kyoto University in Japan and a senior investigator at the Gladstone Institutes in San Francisco. Jaenisch is a founding member of the Whitehead Institute for Biomedical Research and a professor of Biology at Massachusetts Institute of Technology (MIT).

"The Warren Triennial is the top scientific award presented by the MGH, and we are delighted to be able to honor the groundbreaking work of Drs. Yamanaka and Jaenisch," says Daniel Haber, MD, PhD, chair of the MGH Executive Committee on Research and director of the MGH Cancer Center. "Their research has opened up a new direction for the future of medicine, and the MGH is particularly proud to recognize these discoveries in our bicentennial year, in which we will celebrate both the rich history and future promise of biomedical research."

Awarded every third year, the Warren Prize honors scientists who have made outstanding contributions in fields related to medicine and includes a cash award of $50,000. Created in 1871, the prize was named for Dr. John Collins Warren, a co-founder of the MGH who played a leading role in establishing what became the New England Journal of Medicine and also performed the first public surgical operation utilizing ether anesthesia on October 16, 1846. Twenty-two Warren recipients have also received the Nobel Prize, most recently 2004 recipients Craig Mello, PhD, and Andrew Fire, PhD, w
'/>"/>

Contact: Sue McGreevey
smcgreevey@partners.org
617-724-2764
Massachusetts General Hospital
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. L-1 Identity Solutions Awarded New Massachusetts RMV Drivers License Contract Valued at an Estimated $32 Million
2. Journal of General Physiology explores mysteries of TRP channels in latest Perspectives series
3. American Society for Microbiology to host 109th general meeting in Philadelphia
4. General tumor marker test now offered by GenWay clinical laboratory
5. TWAS 11th General Conference
6. HFSP President Arima and Secretary General Winnacker awarded for fostering cooperation with China
7. Modern man found to be generally monogamous, moderately polygamous
8. American Society for Microbiology to host 110th general meeting in San Diego
9. Oil Refineries Announces Delay to Annual & Special General Meeting
10. Mass. General researchers develop functional, transplantable rat liver grafts
11. Major moral decisions use general-purpose brain circuits to manage uncertainty
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... animals often develop relationships with other group members to ... wild chacma baboons the strategy for grooming activities shows ... just published in the scientific journal Biology Letters ... baboons is not practiced without ulterior motives. To be ... the individual, while grooming another individual can provide access ...
(Date:7/11/2014)... of kidney injury related to the use of hydroxyethyl ... HES molecules, according to a report in Anesthesia ... Research Society (IARS). , The "total mass of HES ... human renal proximal tubule cells (PTCs), concludes the laboratory ... Hospital Wrzburg, Austria. Other factorssuch as differences in ...
(Date:7/11/2014)... that cannabinoid receptor type 1 can inhibit ... and reduce neurotransmitter release. However, some scholars ... increase extracellular Ca2+ influx and increase neurotransmitter ... Tongji Hospital Affiliated to Tongji Medical College, ... used whole cell voltage-clamp and calcium imaging ...
Breaking Biology News(10 mins):Baboons groom early in the day to get benefits later 2In lab studies, hydroxyethyl starch has direct harmful effects on kidney cells 2
... decade and a half of near stagnation, four new drugs ... of a terminal disease, a leading Colorado prostate cancer expert ... and innovative methods of action. One is a bone protective ... and the final one is the first drug tested for ...
... can tell cells to act cancerous, surviving, growing and ... cells with cancerous characteristics to stop growing or to ... does both sometimes promoting tumors and sometimes suppressing ... recently published in the journal Oncogene details ...
... have demonstrated a new and more effective method for ... a research advancement that could have major implications for ... death in the Western world. The treatment method ... Baker could allow doctors to bypass surgery and instead ...
Cached Biology News:4 new drugs will change prostate cancer care 2Study details on-off switch that promotes or suppresses breast cancer 2New ability to regrow blood vessels holds promise for treatment of heart disease 2New ability to regrow blood vessels holds promise for treatment of heart disease 3
(Date:7/10/2014)... (PRWEB) July 10, 2014 OMICS Group’s ... techniques during 18-20 August, 2014 at Double Tree by ... the recent developments in Analytical & Bioanalytical research methods ... , Speaking on this occasion, Dr. Srinubabu Gedela, MD ... Acta conference is a remarkable one in bringing a ...
(Date:7/10/2014)... Calabasas, CA (PRWEB) July 10, 2014 ... academic institutions and professional associations, addressed the challenges of ... & Medical Device Industries” through strategic sourcing. Describing the ... ) with the Supply Chain Management Institute ( SCMI) ... the event on June 24 at the Kroc Institute ...
(Date:7/10/2014)... 10, 2014 On July 9 ... , presented Russia,s first national ... The Company is developing a unique project called ... develops a number of innovative drugs based on monoclonal ... ceremony took place at the International Exhibition "Innoprom 2014" ...
(Date:7/10/2014)... 10, 2014 /PRNewswire-iReach/ -- Tute Genomics, the ... announced an agreement with Lineagen, Inc., to ... NextStep Dx PLUS.  Lineagen, focused on ... disorders, currently offers FirstStep Dx PLUS, ... used by healthcare providers as a first-line ...
Breaking Biology Technology:A Critical Review of Analytical Techniques for Improved Living Standards 2A Critical Review of Analytical Techniques for Improved Living Standards 3A Critical Review of Analytical Techniques for Improved Living Standards 4Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 2Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 3Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 4Dmitry Medvedev Presented BIOCAD the First National "Industry" Award 2Tute Genomics Platform Selected to Provide Clinical Interpretation for Lineagen's NextStepDx PLUS Next-Generation Sequencing-Based Diagnostic Test 2Tute Genomics Platform Selected to Provide Clinical Interpretation for Lineagen's NextStepDx PLUS Next-Generation Sequencing-Based Diagnostic Test 3Tute Genomics Platform Selected to Provide Clinical Interpretation for Lineagen's NextStepDx PLUS Next-Generation Sequencing-Based Diagnostic Test 4
... in Physics from the Public University of Navarre and ... studied the behaviour and properties of nanometric-scale semiconductor crystals. ... Dr Echeverra to study the behaviour of semiconductor crystals ... hundred nanometres (a nanometre is a millionth part of ...
... Corporation (Nasdaq: SIAL ) will be presenting at ... 21st at 12:30 PM ET in New York, NY. Interested ... available at http://investor.sigmaaldrich.com/ .  Users can click the "Webcast" ... Sigma-Aldrich: Sigma-Aldrich is a leading Life Science and ...
... Sept. 15 iPierian, Inc., the leading biopharmaceutical company ... discovery, today announced that FierceBiotech has named iPierian  as ... of the most promising biotech companies in the industry. ... its annual list, which is based on a variety ...
Cached Biology Technology:Ph.D. study of behavior of semiconductor crystals of size less than 100 nanometers 2FierceBiotech Names iPierian as One of the 'Fierce 15' Biotech Companies of 2010 2
Chicken anti-EEA1...
Request Info...
IHC Detection Kit (Broad Spectrum AEC)....
... Cell Dissociation Buffers are membrane-filtered isotonic ... chelating agents and cell-conditioning agents in ... salt solution or Ca2+- and ... of mammalian cells from support substrates ...
Biology Products: